Effects of Botulinum Toxin A Injection on Ambulation Capacity in Patients with Cerebral Palsy

Area of Science:

• Pediatric Neurology
• Rehabilitation Medicine
• Movement Disorders

Background:

• Cerebral palsy (CP) is a common neurodevelopmental disorder affecting motor function.
• Lower extremity spasticity significantly impacts ambulatory capacity in children with CP.
• Botulinum toxin A (BoNT-A) injections are used to manage spasticity.

Purpose of the Study:

• To evaluate the effectiveness of BoNT-A injections combined with rehabilitation therapy.
• To assess changes in ambulatory capacity and spasticity in children with CP.
• To compare this combined approach with rehabilitation therapy alone.

Main Methods:

• A randomized study included 30 children (3-13 years) with CP and lower extremity spasticity.
• Group 1 (n=15) received BoNT-A injections and rehabilitation; Group 2 (n=15) received rehabilitation only.
• Assessments included the Tardieu Scale (TS), Gross Motor Function Classification System (GMFCS), Goal Attainment Scale (GAS), and Visual Analogue Scale (VAS) at baseline, 4, and 12 weeks.

Main Results:

• Group 1 showed significant improvements in TS, GMFCS, GAS, and VAS scores compared to baseline.
• The improvements in Group 1 were statistically significant (p < 0.001 for TS, p < 0.05 for VAS).
• No specific comparative results between groups were detailed, but the focus was on Group 1's improvements.

Conclusions:

• Rehabilitation protocols combined with BoNT-A injections are superior to rehabilitation therapy alone for children with CP.
• This combined approach enhances ambulatory capacity in pediatric CP patients.
• BoNT-A therapy offers a valuable adjunct to traditional rehabilitation for improving motor function in CP.